Volume 28, Number 3

Table of Contents

Articles

A Risk-Based Approach to Cleaning Validation using Visible Residue Limits

by Richard J. Forsyth, Jeffrey L. Hartman
This article describes the development of a Visible Residue Limits (VRL) program in a pharmaceutical manufacturing facility, including sample and viewing parameters. Opportunities for VRL implementation were identified in both pilot plant and manufacturing settings.

GAMP 5 Quality Risk Management Approach

by Kevin C. Martin, Arthur (Randy) Perez
This article describes how the GAMP 5 quality risk management strategy offers a pragmatic approach to computer systems compliance.

Creating Quality by Design/Process Analytical Technology (QbD/PAT) Management Awareness

by Christian Woelbeling
This article summarizes the first four chapters of the PAT awareness document created by the PAT COP and explains how QbD/PAT management awareness can be created.

Industry Interview Series: Ruediger Dorn, Managing Director, Worldwide Pharmaceutical Industry, Microsoft

In this interview, Ruediger Dorn discusses Microsoft’s focus on the life sciences and the evolving relationship between plant operations and IT. Speaking from experience in auto manufacturing, he gives his thoughts on current challenges in the pharmaceutical industry.

Domain Methodology for Computer System Specification and Verification Applied to Manufacturing Execution Systems (MES)

by Joseph F. deSpautz, Gregory Ruklic
This article summarizes the domain methodology described in the GAMP® Good Practice Guide on Manufacturing Execution Systems currently under development.

Corrective Action Preventive Action (CAPA): A Risk Mitigating Quality System

by Gamal Amer
This article identifies ways to mitigate the risk associated with the manufacture of drug products.

NOTE: Pharmaceutical Engineering article PDF documents are not to be posted on any Web site, blog site or page, or any other internet site without prior permission from ISPE. (Copyright © ISPE. All rights reserved.)